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In 1990, the Human Genome Sequencing Project was established. This laid the ground
work for an explosion of sequence data that has since followed. As a result of this effort, the
ﬁrst complete genome of an animal, Caenorhabditis elegans was published in 1998. The
sequence of Drosophila melanogaster was made available in March, 2000 and in the
following year, working drafts of the human genome were generated with the completed
sequence (92%) being released in 2003. Recent advancements and next-generation
technologies have made sequencing common place and have inﬁltrated every aspect of
biological research, including parasitology. To date, sequencing of 32 apicomplexa and 24
nematode genomes are either in progress or near completion, and over 600k nematode EST
and 200k apicomplexa EST submissions ﬁll the databases. However, the winds have
shifted and efforts are now refocusing on how best to store, mine and apply these data to
problem solving. Herein we tend not to summarize existing X-omics datasets or present
new technological advances that promise future beneﬁts. Rather, the information to follow
condenses up-to-date-applications of existing technologies to problem solving as it relates
to parasite research. Advancements in non-parasite systems are also presented with the
proviso that applications to parasite research are in the making.
Published by Elsevier B.V.

1. Introduction
David Smith, the former Director of the US Department
of Energy’s Human Genome Program once commented:
‘‘Some years ago, the central idea or dogma in molecular
biology research was that information in DNA directs RNA,
and RNA directs proteins. Today, I think there is a new
paradigm to guide us: Sequence implies structure, and
structure implies function..If you really understand the
relationship between sequence and function, you can begin
to design sequences for particular purposes. . .’’ (Evolution
of a Vision: Genome Project Origins, available on
the Internet http://www.ornl.gov/sci/techresources/
Human_Genome/publicat/97pr/evolve.html).

* Corresponding author. Tel.: +1 301 504 8754; fax: +1 301 504 8979.
E-mail address: Dante.Zarlenga@ars.usda.gov (D.S. Zarlenga).
0304-4017/$ – see front matter . Published by Elsevier B.V.
doi:10.1016/j.vetpar.2009.06.010
U.S. government works are not subject to copyright.

Such an insightful statement made in 1995 was
predicated upon huge amounts of DNA sequence data
becoming available, the creation of high-throughput
systems for studying proteins, and the development of
computer algorithms to assimilate this data to problem
solving. With the advent of next-generation technologies,
sequencing efforts once envisioned as time consuming and
costly are now coming to fruition. As such, databases are
swelling at startling rates which in turn have improved our
abilities to address more complicated questions.
Some applications of large scale sequencing have
straightforward outcomes such as developing gene-based
diagnostic tests; however, less direct beneﬁts with equally
important downstream applications involve studies on
evolution, the host–pathogen interface, and marker
development such as parasite drug resistance and host
susceptibility to infection. Understanding population
variation and how diversity can impact the ‘‘one-sizeﬁts-all’’ mentality in designing 21st century diagnostics,
drugs and immunotherapies is also receiving more

236

D.S. Zarlenga, L.C. Gasbarre / Veterinary Parasitology 163 (2009) 235–249

attention as more genome and transcriptome sequences
become available. The importance of genetic variation in
human research became evident, when in January 2008, an
international research consortium announced the ‘‘1000
Genomes Project’’ (http://www.1000genomes.org/ﬁles/
1000Genomes-NewsRelease.pdf). The goal of this endeavor was to sequence the genomes of at least a thousand
people from diverse biological and geographical lineages
then create a detailed picture of genetic variation within
the human population. With the existence of a human
scaffold sequence on to which the new data could be
mapped, the feasibility of such a project became possible
because of high through-put sequencing technologies.
Unfortunately, such beneﬁts are not easily adapted to
parasite research inasmuch as the level of genetic variation
expected between 1000 individual human samples is likely
partitioned into any one parasite isolate or population.
Also, the lack of sequence congruence among different
parasite genera is sufﬁciently large to defy the concept of a
single model organism for use in comparative genomics
(Mitreva et al., 2005). Thus the challenges facing those
working on parasites as it relates to genetic variation are
immense. Understanding this variability and its relationship to phenotype predictability will form a foundation for
unilateral intervention strategies.
The following review looks at progress in applying
parasite and host gene sequences to problem solving
rather than summarizing sequence data and technologies
that are currently available. Key research areas involve
drug testing and design, evolution and population genetics,
host–parasite relationships and epigenetics, and host
resistance to parasites. Though applications of genomics
to problem solving in parasitology have been slow to
advance in areas other than DNA testing and diagnosis (to
be discussed in other presentations in this series), they will
in time become a requisite to understanding and creating a
healthy world that has parasites as its nemesis.
2. Drug development
2.1. Integrating genomics and drug validation
In classic reductionist approaches to drug development,
it is rarely evident at the outset which biological pathways
will be lethal to a given pathogen if interrupted. Drug
development nonetheless requires selecting an appropriate target molecule, designing drugs to impede its activity,
and then using high through-put screening to validate that
activity. Other, more random approaches, involve searching for functional activity or predeﬁned endpoints from
extracts of natural products, identifying the speciﬁc
components affective against the pathogen, then synthesizing the compound and subsequent analogues ‘‘ad
nauseam’’ to optimize the deleterious effects. In a perfect
world, using phenotype-based screens in the validation
process is optimal; however, these are not easily obtainable when working with parasites. Inevitably, animal
models are required which mimic the pathogen in its
natural host.
Among the ﬁrst applications of whole-genome and next
generation sequencing to drug validation, was deﬁning the

mechanism of action of the new drug R207910 for treating
Mycobacterium tuberculosis (Andries et al., 2005); the ﬁrst
tuberculosis-speciﬁc drug candidate developed in over 40
years. In this regard, drug-resistant mutants of M.
tuberculosis and M. smegmatis were produced, subjected
to massive parallel sequencing, and their genomes
compared to the sequences of susceptible parental strains.
Point mutations in the mutant strains identiﬁed consistent
changes in the atpE gene in nearly all resistant mutants
indicating that R207910 affects the proton pump of ATP
synthase and that this protein was the most probable
target for drug interaction.
Although the small genome size (4  106 bp) of M.
tuberculosis lends itself to parallel sequencing, a similar
approach was used to validate a new class of anthelmintics. Amino-acetonitrile derivatives (AAD) were recently
shown to be effective alternatives to treating for parasitic
nematodes, even those resistant to most commercially
available drugs (Kaminsky et al., 2008). In this approach,
the authors screened over 600 compounds for anthelmintic activity and performed preliminary tests for efﬁcacy in a
rodent model infected with Haemonchus contortus, followed by secondary studies in large animals. Positive
results warranted a comprehensive program to identify
the mechanisms of action; however, an investigation of
this sort would have been costly if performed in the natural
host. It was determined under drug treatment, that the
free-living nematode Caenorhabditis elegans exhibited
marked effects on several key physiological parameters
similar to those observed in H. contortus, suggesting that
AAD functional activity could be modeled in C. elegans; a
beneﬁt of the genome sequencing era. As with the
discovery of R207910 for treating M. tuberculosis, drugresistant mutants of C. elegans were generated and mapped
by genetic recombination. Large scale sequencing identiﬁed acr-23 as the target gene which encodes a nicotinic
acetylcholine receptor-alpha (nAChR-a) subunit coinciding with the nematode-speciﬁc DEG-3 group of nAChR, and
which is distinct from the nAChR subunits of the
levamisole receptor. Information from the Haemonchus
genome project permitted transferring this technology to
similar experiments with H. contortus AAD mutants.
Results showed that the Haemonchus homologue (des-2)
of acr-23 was indeed part of the same nematode-speciﬁc
DEG-3 group targeted by AAD in C. elegans.
Genomic, transcriptomic and proteomic applications to
the discovery of drugs and vaccines in apicomplexa have
been slow to evolve whether applied to human pathogens
like Plasmodium or to zoonotic organisms like Toxoplasma
and Cryptosporidium. Clearly, a solid foundation of
information exists in that genome sequences, EST
(expressed sequence tag) data and comparative studies
are currently available from a number of apicomplexa (e.g.
Abrahamsen et al., 2004; Carlton et al., 2008; Lau, 2009;
Striepen and Kissinger, 2004) along with a complete
complement of mining programs and websites. However,
unlike comparative studies in nematodes which have used
C. elegans as a model for discovery (e.g. Dieterich et al.,
2008; McCarter, 2004; Mitreva et al., 2004, 2005; Yin et al.,
2008), drug discovery with apicomplexa is currently
relegated to mining databases followed by transcriptional
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analyses (Wu et al., 2003). This is due in part to the
completion of many protozoan genome sequences only
recently, the lack of biological, biochemical and genetic
congruence among the important parasite groups, the
inability of most of these organisms to survive in
continuous culture, and the lack of an in vivo model
system. However, the use of one protozoan, Toxoplasma
gondii, seems to be breaking through this barrier at least in
targeted circumstances (Boothroyd et al., 1995; Roos et al.,
1999; Striepen and Kissinger, 2004; Kim and Weiss, 2004).
Experimental and genetic manipulations of T. gondii are
well suited to laboratory studies. In one example, T. gondii
was used to validate a class of drugs (compound 1) for
treating Eimeria. By generating genetic mutants similar to
the validation of AADs, compound 1 was shown to
speciﬁcally inhibit cyclic GMP-dependent protein kinase
(Donald et al., 2002) in both T. gondii and Eimeria.
Toxoplasma gondii was also used to study chemotherapeutic targets in Cryptosporidium parvum using genetic
complementation and genomic insertion (Striepen et al.,
2002). The authors demonstrated the ability to shuttle
cloned C. parvum genomic DNA between bacterial plasmids and T. gondii and in so doing identiﬁed the inosine 5monophsphate dehydrogenase homologue from C. parvum.
This gene is involved in purine salvage that is essential for
parasite development and therefore a likely target for drug
intervention. Thus, analogous to C. elegans, the accessibility
of T. gondii as an experimental system allows its use as a
surrogate to ask many questions that cannot be easily
handled in homologous systems (Kim and Weiss, 2004;
Roos et al., 1999). In like manner, the utility of this model is
targeted rather than holistic.
2.2. Identifying targets for drug or immune intervention
While a genomics approach was used to validate AADs
and R207910 for treating gastrointestinal parasitic nematodes and M. tuberculosis, respectively, these applications
were nonetheless downstream and subject to inefﬁciencies in the current paradigm for anthelmintic drug
discovery. The most favorable drug targets are those
proteins which are essential for the parasite, sufﬁciently
conserved in sequence and function among focus organisms, and either do not exist or differ appreciably from host
physiology. It is also important that the organisms do not
have alternative pathways by which they can circumvent
drug intervention. Pre-screening against these and other
factors has yet to reach mainstream modern drug
discovery. Thus, methods that systematically exploit
sequence information are needed to identify putative
target proteins earlier rather than later in the drug
development process. This has become evident in human
antiparasite drug discovery, where less than 1 in 50 of the
‘‘superior’’ drug candidates make it through clinical trials
and to the market (Brown and Superti-Furga, 2003); the
balance fail either in target identiﬁcation or chemistry.
McCarter (2004) presented an example of how C.
elegans and comparative genomics can be used to
prescreen or ‘‘ﬁlter’’ EST data for candidate pathogen
(nematode) protein targets. The ﬁrst screening parameters
limited target sequences to only those conserved among
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Phylum members and lacked recognizable homologues
among higher Metazoa. These ‘‘ﬁlters’’ alone reduced
putative protein targets from 20,000 to 1200. After
invoking additional ﬁlter criteria such as RNA interference
(RNAi) phenotype, prioritization, and functional classiﬁcation, the ﬁnal list included among others, 3 proteins not
present in mammals; (1) chitin synthase chi-1, which is
predominantly associated with eggshell development; (2)
fatty acid/retinol-binding proteins far-1 and far-3, which
scavenge host fatty acids and retinoids, and/or compromise the host immune response, and; (3) fat-2, a Ä-12 fatty
acid desaturase, which is essential at numerous steps in
the cascade of nematode development. Prior studies
(Stadler et al., 1994) had shown that naturally occurring
fatty acids possessed nematicidal activity. Years later,
Williams et al. (2005) demonstrated that the C-12 position
in fatty acids with structures similar to oleic and linoleic
acid was a key functional site. While the work by McCarter
(2004) took place long after the ﬁrst identiﬁcation of
nematicidal activity in fatty acids, it nonetheless validated
genomic ﬁltering as a viable approach to identifying drug
targets.
A somewhat different approach was used to ﬁnd
putative drug targets in Brugia malayi (Kumar et al.,
2007), where gene selection began not with ESTs but with
RNAi orthologues in C. elegans that generate non-wild type
phenotypes. The investigators reasoned that if these genes
were necessary for C. elegans growth and development,
orthologues would be similarly indispensable in B. malayi.
Approximately 3000 B. malayi genes had RNAi orthologues
in C. elegans; however, most of these shared commonality
with the human dataset and were removed from
consideration, leaving 589 ﬁrst-pass candidates. Given
that 589 genes comprised far too large a dataset to assay,
additional ranking was done according to an algorithm
deﬁned by Hasan et al. (2006) where gene selection was
rewarded for; (1) homology with C. elegans genes; (2)
growth-essential characters deﬁned by RNAi in C. elegans;
(3) stage speciﬁc expression with ‘‘all stages’’ being most
heavily weighted; (4) the presence of druggable protein
domains (sequences that favor drug binding based on
known drug targets) and; (5) expressability in soluble form
in a bacterial expression system. Conversely, sequences
were heavily penalized for having host (i.e. human)
orthologues. Predictably, the top 40 genes using this
mechanism of pre-screening included the chitin synthase
and the family of fatty acid desaturases identiﬁed by
McCarter (2004) and elsewhere (Williams et al., 2005),
along with 10 other proteins of known or previously
proposed targets. The molecular-target approach has been
proposed for protozoan diseases as well (Frearson et al.,
2007) where target validation and druggability are
considered the most important parameters of a successful
drug-discovery program.
Some mining tactics have become more focused and
predicated upon conserved genes associated with metabolic functions in the nematode intestine; a key area for
nutrient digestion and absorption. In this regard, Yin et al.
(2008) examined 77% and 63% of the total genes available
from the Ascaris sum and H. contortus databases, respectively. When compared to the C. elegans database, a subset
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of 241 intestine-based genes (IntFam-241) was generated.
These genes were conserved among all species and were
deﬁned as putative targets for effective parasite control.
Caffrey et al. (2009) were interested in identifying
alternative drug targets to treat Schistosoma mansoni. In
this approach, the authors compared and contrasted the
putative proteomes of S. mansoni with both C. elegans and
the fruitﬂy D. melanogaster to identify orthologues for
which disruption would yield deleterious phenotypes in S.
mansoni. They used distinct selection criteria or workﬂows
to generate 2 protein subsets and from among these
selected genes that appeared in both subsets. Of the 13,283
predicted gene products of S. mansoni, 35 orthologous
proteins were identiﬁed with druggable characteristics
among which 3D structural information is available on 18
of these protein families.
Pharmacogenomics is a tactical diversion from the ‘‘onesize-ﬁts-all’’ mentality in drug development and is currently
being evaluated in human disease research. The common
dogma of pharmacogenomics involves an appreciation for
the relationship between genetic polymorphism and
effective drug treatment, where predetermined knowledge
of the mode of action can guide researchers towards those
drug(s) most likely to prove efﬁcacious. A second, less
conventional component of pharmacogenomics is developing ‘‘designer’’ drugs directed at a subset of organisms
responsible for the greatest disease, rather than targeting
proteins that are conserved among the broadest group of
organisms. To date, this approach has garnered interest only
in abrogating Plasmodium species. The use of AT-speciﬁc
DNA-reactive drugs ﬁrst used by Cristofanilli et al. (1998) to
treat metastatic breast cancer, were secondarily evaluated
by Yanow et al. (2006) and Woynarowski et al. (2007) to
target ‘‘AT-rich islands’’ in P. falciparum. In particular, 2
drugs bizelesin and adozelesin that alkylate 30 ends of
adenines within these AT-rich islands were tested given that
P. falciparum consists substantially (80%) of AT bases.
Promising results in killing the parasite, coupled with
disappointing results on host toxicity, have prompted
continuing efforts to develop less toxic designer drugs
predicated upon a holistic understanding of the genetic
makeup of the pathogen (Yanow et al., 2008). The important
component of this research is that this class of drugs targets
nucleic acid primary structure rather than proteins. As we
become better at predicting and validating secondary
structure among nucleic acids, drugs causing damage to
these molecules maybe less subject to parasite resistance
and may ﬁnd their way to the market place.
2.3. Limitations to parasite models in drug discovery
It is clear that C. elegans has become the poster child for
nematode research. Its use as an ‘‘incubator’’ for studying
pathways among nematodes and even among higher
Metazoa is well established (Grant, 1992); however, using
C. elegans to explore parasitism has been slow to unfold,
exposing the current limitations to such a model. Classic
functional genomics began with ground breaking work
using double-stranded RNA (dsRNA) to interfere (RNAi)
with translation through premature mRNA degradation.
The technology was pioneered by Fire et al. (1998) and ﬁrst

applied to study genome-wide regulation in C. elegans
(Kamath and Ahringer, 2003; Ashraﬁ et al., 2003; Simmer
et al., 2003). This work was predicated on the fully
characterized genome and transcriptome of C. elegans,
which provided fewer obstacles for culturing and evaluating phenotypic changes. In addition, numerous methods
had been developed to introduce dsRNA into the nematode. It was assumed that this technology could be easily
transferred to other nematode genera; however, RNAi
studies on parasitic nematodes such as Ostertagia (Visser
et al., 2006), Haemonchus (Geldhof et al., 2006) and
Heligmosomoides (Lendner et al., 2008) among others,
have met with sporadic and equivocal results, so much so
that some have questioned whether the RNAi pathways are
present in modiﬁed form or even exist in many parasitic
nematodes (Knox et al., 2007; Viney and Thompson, 2008).
Within currently available nematode EST databases, 35–70%
of the genes in any one species overlap with that of C. elegans,
the balance are conserved among higher taxa or to a large
extent unique to speciﬁc taxa. Thus, in order to perform
functional studies on the broad group of sequences that are
unique or shared among limited taxa and not with C. elegans,
other ‘‘model’’ systems will need to be developed that better
represent subclasses of worms. In the absence of RNAi
machinery comparable to that of C. elegans, it may become
necessary to genetically engineer other nematodes to render
them more amenable to RNAi studies (Viney and Thompson,
2008). Still, ﬁnding ways for high-throughput RNAi screening in parasitic nematodes will provide challenges unlike
those observed in free-living organisms.
A second caveat to using models and moleculartargeting to mine nematode genomes or transcriptomes
lies in applying universal constants to screen or ﬁlter
datasets among disparate species. Namely, if a given subset
of genes must be orthologous to those present in C. elegans
as grounds for mining nematode sequences, such ﬁltering
criteria will inevitably produce undesired and predetermined commonality among the species subsets as the
databases mature. Case in point, completely different
approaches used to mine the C. elegans (McCarter, 2004)
and B. malayi (Kumar et al., 2007) transcriptomes for drug
targets generated substantial overlap in the ‘‘common
genes’’ because of overlapping ﬁltering criteria, undermining the intended independence of such searches.
3. Phylogenomics and ‘‘the tree of life’’
In concert with the increasing repertoire of completed
genome sequences, the ﬁeld of phylogenetics has
expanded to reconstructing evolutionary histories based
upon their whole genomes, now coined ‘‘Phylogenomics’’
(Eisen, 1998; O’Brien and Stanyon, 1999; Eisen and Fraser,
2003). As with conventional molecular systematics,
inference of evolutionary trees using genomic data is
predicated on robust sequencing efforts, followed by
careful assignment and assembly of homologous and/or
orthologous genes (usually > 100). From here, phylogenomics can be further subdivided into sequence-based and
non-sequence-based analyses.
Sequence-based phylogenomics relies on the data being
concatenated into a supermatrix and analyzed as a single
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entity. Alternatively, the individual genes can be analyzed
separately to account for independent evolutionary
histories, than combined into supertrees. These
sequence-based approaches are similar to those commonly used today for individual genes but are applied to
much larger and more diverse datasets.
To optimize the use of whole genomes for phylogenetic
reconstruction beyond the level of primary sequence, nonsequence-based trees can also be inferred by comparing
whole-genome features such as shared gene content (the
fraction of shared orthologues between 2 genomes) (Snel
et al., 1999), conservation of gene order (Korbel et al.,
2002), ‘‘DNA strings’’ (the distribution and frequency of
short-oligonucleotide or peptide combinations) (Delsuc
et al., 2005; Philippe et al., 2005a), and intron positions
(Roy and Gilbert, 2005). These methodological approaches
do not rely on multiple-sequence alignments to infer
phylogeny but look at the character make-up of the whole
genome. One advantage to these methods is that the large
character-state space reduces the risk of homoplasy by
convergence and reversal (Philippe et al., 2005a) and
therefore may result in more reliable phylogenies.
Furthermore, sampling (stochastic) error, which is a caveat
of phylogenetic trees based upon a few genes, should
eventually be minimized as the datasets continue to
increase (Rokas et al., 2003).
3.1. Parasite evolution
With parasites, phylogenomics is in its infancy owing to
the paucity of completed genome sequences. Nonetheless,
this technology has been used to evaluate seven apicomplexa using 268 single-copy genes (71,830 aligned amino
acid sites) suitable for phylogenetic inference (Kuo et al.,
2008). The data were analyzed using predicted protein
sequences, which evolve slowly enough to retain phylogenetic signal in lineages that may have begun diverging
from one another 700–900 MYA (Douzery et al., 2004). The
authors demonstrated that the topologies of their trees
were consistent with those generated from ultrastructural
and developmental characters. Incongruence was common
among the 48 individual trees used to construct the
supertree, and only 19% of the 268 single-copy genes
examined offered strong support for the apicomplexan
species tree; the next 7–10% of the genes differed in the
placement of C. parvum. The authors concluded that
limiting the analysis to a small subset of sequences
conserved among all apicomplexan lineages may have
inadvertently excluded more distinct, yet phylogenetically
informative, sequences. This has been claimed as a key
factor in generating misleading tree topologies (Jeffroy
et al., 2006; Philippe et al., 2005a). A subset of genes (19%
or 51 genes) was nonetheless generated as a collection of
candidate sequences for future phylogenetic analyses.
Phylogenomics was also used to examine lateral gene
transfer (LGT) in apicomplexa, predominantly C. parvum
(Huang et al., 2004a,b; Striepen et al., 2004). Results are
consistent with plant-like genes present in apicomplexan
parasites, such as C. parvum, that lack a plastid organelle
i.e. the apicoplast. At least 31 genes of putative plastid/
endosymbiont (n = 7) or prokaryotic (n = 24) origin have
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been identiﬁed (Huang et al., 2004a) and suggest that
Cryptosporidium may have arisen from a plastid-containing
lineage, and thereafter lost its apicoplast. These studies
explain in part why commonly used drugs against
apicomplexa are unsuccessful in treating cryptosporidiosis. Lateral gene transfer from high-throughput sequencing
has also been proposed for root-knot nematodes (Scholl
et al., 2003) where rhizobia genes have been identiﬁed in
Meloidogyna spp. using screening ﬁlters for phylogenetic
incongruency. In general, identifying LGT can be quite
difﬁcult because of the inability to differentiate it from
other evolutionary events, such as strong selection,
unusual rates of change, and gene loss (Eisen and Fraser,
2003).
Deﬁning hierarchical relationships among nematodes,
arthropods and vertebrates is one of the most puzzling
issues in animal systematics and evolutionary biology. The
prevailing hypotheses are comprised of Coelomata or
Ecdysozoa clades. The Coelomata hypothesis suggests that
arthropods are more closely related to chordates than to
nematodes, whereas the Ecdysozoa hypothesis contends
that arthropods are genetically more closely linked to
nematodes than to chordates. Varying the choice of gene(s)
and protein(s) has been unable to resolve this issue
because of problems using small datasets to evaluate deep
evolutionary events. In 2004, Wolf et al. (2004) used
phylogenomics to analyze over 500 protein sequences by
generating a supermatrix from concatenated sequences
and a supertree from optimized individual trees. They
further analyzed their data using gene-content (presence/
absence), domain co-occurrence, and indels, all of which
quantitatively showed convergence on coelomate topology. In that same year, Dopazo et al. (2004) used genecontent to examine 25,000 amino acid sequences corresponding to >3000 genes. Similar to Wolf et al. (2004),
their data unequivocally rejected the Ecdysozoa clade.
Copley et al. (2004) examined 1712 orthologous genes and
2906 protein domains to study this same problem. Initially,
their results strongly supported the Coelomata grouping as
well; however, they did not account for substantial
character loss inherent in C. elegans, which was used as
the model nematode in this analysis. Once considered,
Copley et al. (2004) found their data was more in line with
the Ecdysozoa hypothesis. The following year, Dopazo and
Dopazo (2005) found that contrary to their original
analysis (Dopazo et al., 2004), a transition from Coelomata
to Ecdysozoa clades occurred if fast-evolving sequences in
C. elegans were removed from consideration. Dopazo and
Dopazo (2005) further showed that gradual adjustments
toward equal evolutionary rates between nematode and
arthropod sequences shifted support from Coelomata to the
Ecdysozoa hypothesis. This work was corroborated by
Philippe et al. (2005b).These data demonstrated that long
branch attraction biases can affect positioning of taxa on
phylogenetic trees even when whole genome data was used.
3.2. Phylogenomics; panacea or puzzle?
Although large datasets presumably minimize sampling errors, systemic errors or compositional biases must
still be accounted for in tree reconstructon (Jeffroy et al.,
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2006). As example, whole genome data analyzed using
maximum likelihood and parsimony methods (Rokas et al.,
2003) resulted in a tree with 100% bootstrap support.
When this same data was reanalyzed using minimum
evolution, an alternative tree was generated that also
received 100% bootstrap support (Phillips et al., 2004).
Simply recoding the nucleotides as purines and pyrimidines (RY-coding) reinforced the original tree proposed by
Rokas et al. (2003). Thus, caveats to these methodologies
involve using probabilistic methods for analysis and
phylogenetically misleading data (Jeffroy et al., 2006;
Philippe et al., 2005a) where uncertainty in how best to
model the evolution of genomes may limit the applicability
of available reconstruction methods. Furthermore, bootstrap replicability merely testiﬁes that a given method
consistently reaches the same result when applied to a
given dataset but does not guarantee the accuracy of that
result to reﬂect the genome’s evolutionary history.
Inadequate-taxon sampling can also result in robust
bootstrap values which do not reﬂect the true tree. One
test for correct topology is the ability to generate
congruent trees with both taxon-poor and taxon-rich
sampling (Philippe et al., 2005a).
Clearly, using whole genome information in phylogenetic reconstruction is not yet the panacea originally
envisioned in solving the tree of life. Problems still exist in
how best to utilize the datasets and how to deal with biases
that can ‘‘sway’’ the topology of a tree. However, tree
topologies based upon whole genome sampling relative to
conventional trees predicated upon one or a few genes are
less affected by rare genomic changes such as unrecognized horizontal gene transfer, indels, misalignment, and
to an extent, even missing data (Philippe et al., 2004). As
we learn more about working with large datasets, deﬁning
reliable characters and the bases for inconsistencies, there
is the hope that phylogenies will coalesce into the single
true topology.
4. Genomes, transcriptomes and population genetics
4.1. Single nucleotide polymorphism and genetic variation
Twenty-ﬁve years ago, population genetics was relegated to comparing morphological and biological data
among isolates. Today, scientists can use mass spectrometry and associated methodologies to perform 250,000
assays a day for single nucleotide polymorphisms (SNPs)
and at an error rate of less than one in 10,000. This is
particularly important when using large datasets to
associate disease states with one or more common alleles.
Population studies involving sequence variation at the
level of whole genomes are scant among parasites
primarily because reference sequences are required for
comparative work and less than a handful of whole
genome sequences are available. Hillier et al. (2008) used
massive parallel, short read (35 bp) sequencing (Solexa) on
C. elegans to reveal genome-wide variation in the form of
single nucleotide polymorphisms (SNP) that can be
applicable to evolutionary studies or correlating genetic
markers to phenotypic characters. The availability of the
whole genome of Plasmodium falciparum has led to

comparative studies on natural selection (Neafsey et al.,
2008), barcoding for isolates identiﬁcation (Daniels et al.,
2008), and worldwide genetic diversity (Volkman et al.,
2007). Unfortunately, genome-wide SNP studies with
parasitic nematodes have been far less fruitful given the
high genetic variation that exists among populations and
the debatable need to evaluate the entire genome for
phenotypic markers. As such, scientists have begun using
genome subsets for population studies. Bekal et al. (2008)
identiﬁed SNPs among 2 highly inbreed biotypes of the
soybean cyst nematode, Heterodera glycines that differed
dramatically in their levels of virulence. This approach
used incomplete genome sequence data for SNP identiﬁcation by focusing on a single BAC clone as the reference
sequence. This was followed by massive parallel sequencing of the virulent and avirulent strains using 454 microbead DNA technologies, and then comparing both datasets
to the BAC sequence. Results demonstrated that 84% of the
identiﬁed SNPs were correct. Van der Veer and de Vries
(2004) tackled the problem of genetic variation by focusing
on the mitochondrial genome of Cooperia onchopora which
has only 525 bp of non-coding DNA. Unfortunately, their
results demonstrated a rate of 1 polymorphic site every
32 bp. This far exceeds the average rate observed in the
human nuclear genome (The International SNP Map
Working Group, 2001) but does not vary substantially
from that observed among nematode genomic sequences.
Such variation renders identiﬁcation of informative SNPs
problematic even with sufﬁcient taxon sampling.
As a result of the large genetic variability in non-coding
DNA, studies using SNP markers have been relegated to
individual genes or open reading frames i.e. ESTs.
Phenotypic changes such as benzimidazole resistance
have been associated with point mutations in the tubulin
gene (Kwa et al., 1994; Von Samson-Himmelstjerna et al.,
2007). Others have generated putative SNP markers
assimilating Ivermectin resistance with P-glycoprotein
(Bourguinat et al., 2008) and b-tubulin (Bourguinat et al.,
2007), and for differentiating among Cyclospora and
Eimeria species (Orlandi et al., 2003). Simões et al.
(2007) used S. mansoni as both the target and model
species to evaluate whole transcriptomes. They developed
an automated pipeline consisting of 16,000 SNPs from
107k public ESTs sequences to detect SNPs in silico using
high quality data and alignment parameters. Nonetheless, it
is clear that until programs are developed to help weed
through genetic ‘‘noise’’, most SNP work will be relegated to
less variable transcriptomes (Von Samson-Himmelstjerna
and Blackhall, 2005; Gilleard, 2006). Efforts are being
advanced in other ﬁelds to develop programs that can
evaluate SNPs in highly pooled, genetically diverse DNA
samples (Homer et al., 2008a,b). Targeting genes encoding
highly expressed proteins may provide additional beneﬁt.
When Drummond et al. (2005) studied the rate of protein
sequence evolution, they found that proteins evolve at rates
inversely associated with their levels of expression and not
in concert with protein function. Thus the most highly
expressed proteins are believed to evolve more slowly and
may provide some stability in SNP analyses if targeted.
Others contend that functional constraints on protein
evolution should not be neglected (Wolf et al., 2008).
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4.2. Microsatellites, genetic variation and anthropogenic
effects
Marker types such as microsatellites (MSAT) are also
being studied to circumvent the ambiguity associated with
deﬁning reliable SNPs. Microsatellites or Simple Sequence
Repeats are short repeat sequences usually 2–8 base pairs
in length most often found in non-coding DNA. These
sequences are presumed not to undergo selection and are
repeated in tandem > 8 times. Consequently, variation in
the length of the repeats can be used to score these allelic
loci. As with SNPs, many MSAT studies involve one or a few
markers (Casulli et al., 2009; Grillo et al., 2006; Morlais
et al., 2001) where identiﬁcation is predicated upon
extensive and speciﬁc cloning protocols followed by
validation (Johnson et al., 2006). Webster et al. (2008)
used large scale cloning to identify MSAT markers that
address the disparity in benzimidazole resistance among
nematodes infecting avian and livestock hosts. They
postulated that the absence of resistance alleles in avian
nematodes may result from alternative mechanisms in this
system, or that selection pressures may not be the same
between avian and livestock hosts.
As databases continue to expand, it will become more
commonplace to mine genomes and EST for MSATs,
thereby eliminating the extensive cloning steps (Rodrigues
et al., 2002). Programs such as TRF (Benson, 1999), TROLL
(Castelo et al., 2002), STRING (Parisi et al., 2003), Mreps
(Kolpakov et al., 2003), and TRAP (Sobreira et al., 2006)
have been used successfully for this purpose. The
advantages of having genome sequence data can be seen
in the recent work by Rosenthal et al. (2008) who scanned
the near complete genome of Trichinella spiralis for MSAT
markers. They identiﬁed and validated 9 targets that could
be reproducibly ampliﬁed in all species and genotypes of
Trichinella known to date. To understand the population
structure of this genus, the authors evaluated hundreds of
isolates spanning 28 countries and 4 continents using
these MSAT markers. They concluded that other than for
speciﬁc regions in Central Asia, T. spiralis found in pigs
worldwide is basically the same population. They concluded that this species was likely dispersed by European
colonists in only the past several hundred years as a
consequence of host translocation and modern agricultural
practices.
Similar techniques have been used in population
studies of apicomplexa. Mining the Plasmodium vivax
genome, Karunaweera et al. (2007) identiﬁed 14 MSATs
that were used to study worldwide population diversity
(Karunaweera et al., 2008). When they examined 164
isolates from 4 continents, they found 150 unique,
multilocus haplotypes characteristic of extensive genetic
diversity, with signiﬁcant multilocus linkage disequilibrium in local populations; however, they saw no
signiﬁcant geographic clustering. They concluded that
human infections followed by host relocation and parasite
relapses, which are common in P. vivax infections, likely
resulted in dissemination of strains across broad geographical localities and that this occurred very recently. They
also suggested that the modest diversity among some local
populations could lend itself to mapping loci associated
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with virulence or drug resistance. Programs are being
developed to accurately assess MSAT allele frequencies in
pooled samples or in the case of parasites, to deal with the
genetic variation that exists among individuals in a single
population (Schnack et al., 2004; Silva et al., 2006).
Using a whole genome ‘‘ﬁngerprinting technique’’ i.e.
ampliﬁed fragment length polymorphism, which is independent of sequence data, Nejsum et al. (2005a) demonstrated a similar but more local effect in Ascaris suum. They
found that A. suum populations among farms in Denmark
were essentially homogeneous and indicative of free gene
ﬂow among geographical localities, or common recent
origins similar to that observed with T. spiralis. The
underlying concern is that once established, anthelmintic
resistance is likely to spread rapidly among the Danish pig
population. This is particularly intriguing in light of
preliminary epidemiological evidence suggesting that
Danish patients can acquire Ascaris infections from
domestic pigs, raising concerns over A. suum as a zoonoses
(Nejsum et al., 2005b).
4.3. Indels as genetic markers; a new solution to an old
problem?
New approaches are being developed to address high
amounts of genetic variability by targeting small insertions
and deletions (indels) rather than SNPs or microsatellites
(Nairz et al., 2007). Indels are normally far less frequent
than are SNPs. Studies in C. elegans found that indels
constitute between 25% and 28% of all polymorphisms
(Wicks et al., 2001; Swan et al., 2002) and that most of
these are in the order of 1–2 bp. Simple analysis on
Elchrom gels or capillary sequencers make this approach
amenable to high-throughput screening if the application
reaches mainstream (Nairz et al., 2007). Recently, a large
scale analysis of 214,000 polypeptides from 32 nematode
species identiﬁed insertions and deletions unique to
>1000 families of nematode proteins (Wang et al.,
2009). Among these, the authors identiﬁed three sizable
deletions that are speciﬁc to parasitic nematodes and as
such maybe targets for drug design.
5. Genomics and host–parasite relationships
5.1. Genomics vs. epigenomics
With the discovery in China of the primitive bird
Archaeopteryx, an intermediary link between avian
evolution and dinosaurs was substantially conﬁrmed
(Asara et al., 2007; Schweitzer et al., 2007). Surprisingly,
using a gene known to induce tooth formation, Harris et al.
(2006) demonstrated that they could regenerate archosaurian teeth in chick embryos and alter the oral/aboral
boundary of the jaw. Using similar methods, embryonic
chickens produced tails with 16-vertebrae more representative of reptiles than the four to eight vertebrae
present in spines of normal developing chickens (http://
www.dailymail.co.uk/sciencetech/article-1026340/). Such
captivating ﬁndings and particularly in the embryonic
stages demonstrate that seemingly ‘‘lost’’ genes persist in
the chicken genome but are subjected to changes in
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developmental control. This raises intriguing questions
linking epigenetics, or heritable non-genetic factors, to the
way an organism’s genes behave, where environmental
forces (and not merely gene content) affect the phenotype
of an organism. It further tempers what we can glean from
whole genome sequences only. David Allis of Rockefeller
University, New York, once commented;
‘‘The Human Genome Project. . . provided the blueprint for
life, but the epigenome will tell us how this whole thing
gets executed’’ (Bradbury, 2003).
Epigenetics is the study of developmental regulation at
the cell level where mechanisms such as histone modiﬁcation, methylation, and gene silencing via small RNAs,
regulate chromatin structure and cause genetically homogenous cells to be phenotypically heterogeneous. Some
have even suggested that histones and other regulators of
chromatin structure may be viable targets for new
antiparasite drugs (Rawat et al., 2007). Many epigenetic
events are incorporated early on in embryogenesis though
alterations are not limited to this period of development.
Evidence for conservation of epigenetic pathways among
Metazoa has been demonstrated in the nematode C.
elegans (Lee et al., 2004, 2007; Simonet et al., 2007) and
in the Protozoa T. gondii (Gissot et al., 2007; Gissot and Kim,
2008); however, modiﬁcations are not necessarily conserved among parasites in a population. Seemingly
innocuous sequence variation between individual parasites can cause disparity in the way the genomic DNA and
chromatin are recognized and modiﬁed. In the plant
model, Arabidopsis, epigenomic studies showed how
changes in the local sequence composition can affect
DNA methylation and, in turn, the transcript abundance of
hundreds of genes (Lister et al., 2008). Results further
showed that modiﬁcation was not inconsequential in that
nearly 6% of all cytosines in the Arabidopsis genome were
methylcytosine. Extrapolating this to parasites one can
surmise that the manner in which a parasite responds to
drugs or immunotherapy will be dictated not only by its
genetic framework but by epigenetic factors as well. The
relationship between epigenetics and drug resistance in
parasites, however, has received little if any attention; yet,
antiparasite drug treatments are known to affect transcriptome (Natalang et al., 2008; Silveira et al., 2007) and
proteome (Choi et al., 2003; Prieto et al., 2008) proﬁles in
the target organisms. Differences in gene expression need
not be relegated to whole organisms. Recent work looking
at proteome responses of ‘‘genetically identical’’ individual
cancer cells following drug treatment clearly showed
changes in expression levels and localization of proteins
associated with the drug mechanism (Cohen et al., 2008).
Among the 1000 proteins examined, a well-deﬁned subset
was differentially expressed in association with the
outcome of the cell i.e. survival or death.
For a long time, changes in the ability of pathogens to
infect different hosts was attributed to variations in the
host immune response only; however, the proteomes of
the pathogens can change in response to the host.
Substantial incongruence was observed in the soluble
proteins of Heligmosomoides polygyrus bakeri passed
through C57/B10 mice that can house the parasite for

long periods (slow responders), relative to SWR mice that
eliminate the parasite within a few weeks (fast responders)
(Morgan et al., 2006). Using microarrays, similar variations
in transcriptome proﬁles were observed in Strongyloides
ratti subjected to rats exhibiting low or high immune
pressures on the parasite. Collectively, these results
underscore the difﬁculties in identifying vaccine targets
against heterogeneous parasite populations, and demonstrate the affects that changes in the intestinal milieu can
have on the transcriptomes of invading organisms.
5.2. Genomics and the vertebrate host
Having a well-deﬁned host genome makes available a
number of avenues by which the impact of parasites on their
vertebrate hosts can be minimized. The recent completion of
the genome sequence of several vertebrate species provides
a framework for the development of innovative disease
control programs. Upon completing the human genome
sequence in 2003, focus turned to sequencing other species
in the phylogenetic tree and to characterizing the diversity
of these genomes. This resulted in the sequencing of the
whole genomes of two agricultural importance species, i.e.
the chicken (2004) and the cow (2006), and two other
species of veterinary importance i.e. the dog (2004), and the
horse (2007). In addition, the assembly of 10 chromosomes
of the pig was released in 2008. These sequence data have
provided a foundation for identifying inherent structural
variations that inﬂuence host–parasite interactions, as well
as for characterizing metabolic and immunologic pathways
involved in resistance to infection and/or parasite-induced
pathology.
There is overwhelming evidence that susceptibility/
resistance to parasitic infection is inﬂuenced by host
genetics. The importance of genetically controlled resistance has been demonstrated in a large number of
protozoan infections such as leishmaniasis, trypanosomiasis, malaria, giardiasis, etc. (for review see Blackwell,
1988), and in helminth infections involving trematodes
and nematodes (Whitlock, 1955; Gasbarre and Miller,
2000; Crawford et al., 2006; Coppieters et al., 2009).
Arguably, the most extensively deﬁned host–parasite
systems are those involving gastrointestinal nematodes
and their mammalian hosts (for review see Gasbarre and
Miller, 2000). Numerous studies have evaluated the
heritability of genetically controlled resistance, and have
published estimates from below 10% to as high as 80%;
however, most in the ﬁeld would deﬁne this phenomenon
as ‘‘moderately heritable’’ ranging between 20% and 40%.
Part of the problem with accurately deﬁning heritability is
that parasite populations do not often exhibit a normal
distribution among their hosts. Instead, they tend to
exhibit an ‘‘overdispersed’’ distribution, i.e. a negative
binomial distribution (Crofton, 1971a,b). As a result,
traditional statistical methods for estimating heritability
fail to accurately assess this trait because they are designed
for use on data from infections which exhibit normal
distribution patterns. The recent development of a new
data transformation procedure appears to address this
issue and may result in more accurate estimations of
heritability (Silva, submitted for publication).
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Regardless of the broad range of values obtained to
date, it is evident that variations in the host genome can
have a signiﬁcant impact on the course of parasitic
infections. A ‘‘Genomic Toolbox’’ will be a valuable
resource in deﬁning these variations, and in developing
and applying new parasite control programs.
There are 3 major approaches that utilize genomics to
address the parasite–host interface. Each method attempts
to deﬁne the genetic make-up of the vertebrate host and
understand how variation in the genome can inﬂuence the
ability of the host to see and react to parasitic infections.
With this knowledge, one can develop programs to reduce
the rate or intensity of infection, and lessen the physiological impact of the parasite on the host. In order to
demonstrate these 3 approaches we will concentrate on
the relatively well-studied ruminant–gastrointestinal
nematode system.
5.2.1. Association of chromosomal regions and resistance
Success in identifying chromosomal regions inﬂuencing
a given trait requires three important components; the
ﬁrst requirement is a working linkage map. As established
previously, individual animals respond differently to
parasites, and to a signiﬁcant degree this disparity in
responses is the result of genetic variation among hosts.
Initial efforts to identify these genetic anomalies have
focused on correlating speciﬁc physiologic responses to
infection (phenotype) with distinct chromosomal regions
of the host (genotype). In bovine, studies of this nature
became possible following publication of the ﬁrst linkage
map (Barendse et al., 1994) and the subsequent reﬁnement
of this map by Kappes et al. (1997). This map resulted in
the placement of more than 1200 polymorphic markers
over the 29 bovine chromosomes which were separated by
an average distance of 2.5 cM. While these distances are
large, this information allowed identiﬁcation of the ﬁrst
bovine quantitative trait loci (QTL), i.e. distinct regions of
the genome that contain structural variations coincident
with a physiological trait of interest. Most of these markers
were microsatellites, which offered the advantage of
numerous alleles, but had the disadvantage of being
physically distant from one another within the genome; an
estimated 30–40,000 total markers were separated by an
average distance of 70–100,000 base pairs (bp).
The second requirement is a reliable measure that
accurately reﬂects the physiological trait being investigated. In the case of GI nematodes, the trait is resistance to
infection; the measure is the fecal egg count (FEC),
representing the number of eggs passed in the feces.
Analyses of FEC values in cattle herds revealed several
important facts. First if calves are sampled on consecutive
days, the repeatability of FEC values is approximately 0.6
(Gasbarre et al., 1996). This repeatability decreases
dramatically if the time between samples is extended
(Stear et al., 1984). Second, FEC values decrease with the
age of the animal, and change throughout the year based
on grazing behaviour of the animals. Third, the sex of the
animal inﬂuences FEC values where bulls have higher FEC
values than cows (Gasbarre et al., 1990; Stear et al., 1990).
Finally, FEC values are not normally distributed within a
cattle herd but follow an ‘‘overdispered’’ distribution
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(Crofton, 1971a,b; Genchi et al., 1989; Gasbarre et al.,
1993). In such a distribution, where the standard error of
the mean exceeds the mean, most individuals have
relatively low fecal FEC values, and only a small percentage
of animals are responsible for the majority of the eggs
released on the pastures. This results in an apparent group
of susceptible animals or ‘‘non-responders’’ representing
only 15–25% of the total population (Anderson and May,
1985; Genchi et al., 1989).
The third and ﬁnal requirement for QTL identiﬁcation is
a population of animals where the trait can be traced
through a series of generations such that the phenotype (in
this case FEC) can be related to the genotype (i.e. the
microsatellite markers). This resource was produced at the
Agricultural Research Service at Beltsville MD by selectively breeding Angus cattle for susceptibility or resistance
to infection by GI nematodes. These cattle were initially
derived from the Wye Angus herd of the University of
Maryland. This herd was started with 18 registered
yearling heifers and one bull; 10 of the heifers had the
same sire, thus creating half-sisters. No other females were
ever introduced into the herd. Between 1942 and 1958, an
additional 19 bulls were imported from the British Isles
(Lingle and Koch, 2001). As a result, a pedrigree was
produced comprising at least 9 generations that could be
traced back to 1 of 18 dams and 1 of 19 bulls. All calves
were placed at weaning on pastures containing Ostertagia
ostertagi and Cooperia oncophora. The calves are kept on
these pastures for a minimum of 120 days to allow them to
express immunity to the parasite exposure (Gronvold
et al., 1992). During the test period all animals were
monitored weekly, and at the end of the test period some
animals are slaughtered for parasitological and immunological assessment. Using this protocol, over 300 animals
were completely characterized for resistance/susceptibility to the parasites.
An initial whole genome scan was run using 196
markers that were polymorphic in the population. The
results indicated 17 loci on 7 different chromosomes with
statistical correlation to traits of interest. Unfortunately,
the extreme distances between the microsatellites made
further efforts extraordinarily difﬁcult. To lessen this
problem, studies were initiated using SNP rather than
microsatellite markers in the genome scans. A limitation of
SNPs is that they exist in only 2 allelic forms, and as such
are less informative than polymorphic microsatellites. In
their favor, the number of SNPs in cattle is estimated to be
between 7 and 14 million, with an average frequency of
about 1 per 200–400 bp. Thus, large numbers of markers
can be used in whole or partial genome scans and at
sufﬁcient densities to identify informative genome segments and permit re-sequencing of suspect areas. The
recent development of the commercially available Inﬁnium BovineSNP50 BeadChip1 (Illumina, San Diego, CA)
has provided us the tools to addresses this problem. This
chip was developed as a cooperative effort of a private
company and a number of government and University
laboratories. It uses over 50,000 SNPs spread over the
bovine genome to identify markers that can be associated
with traits of interest. In addition to the advantage of
characterizing smaller chromosomal segments, the chip
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also reduces the level of necessary information from
genotype, phenotype, and pedigree to simply knowing the
genotype and phenotype of the animal. Therefore, data
analysis changes from a complex algorithm that traces
associations through generations to a simple Poisson
association of trait and marker(s) (Gibbs and Singleton,
2006). To address the problem of only 2 alleles, adjacent
SNPs can be strung together to yield SNP haplotypes that
cover a region thereby yielding a polymorphic marker
(Gabriel et al., 2002). Similar studies have been generated
elsewhere using both microsatellites and SNPs to ﬁne-map
parasite resistance in Dutch Holstein–Friesian dairy cattle.
These studies involved 4000 animals and genotypes from
more than 750 within-family extremes (Coppieters et al.,
2009). Their results revealed two chromosome segments
with strong evidence for QTL, and these corresponded with
orthologous positions in sheep discovered by Crawford
et al. (2006) and Beh et al. (2002).
5.2.2. Identiﬁcation of structural variations that inﬂuence
resistance
The identiﬁcation of chromosomal regions containing
structural variations affecting traits of interest provides an
opportunity to isolate and deﬁne speciﬁc genes associated
with the phenotype. Structural variation can take on
various forms, from a single base difference to large
chromosomal rearrangements (Feuk et al., 2006). More
traditional approaches have involved an examination of
the identiﬁed area for likely gene candidates, eg. immune
response genes. Once a subset of target genes were
identiﬁed, variation in the genes and their regulating
sequences in animals with differing phenotypes were
determined by standard molecular techniques such as PCR.
Unfortunately, such approaches are limited by a priori
assumptions of the physiology of the trait. Additionally
structural variations outside of the genes themselves will
be missed, as will major structural anomalies such as copy
number variation (CNV).
Newer genomic technologies offer a variety of methods
to characterize important structural variations. The
detection of large variations such as CNV can be addressed
through a combination of specialized microarrays and next
generation sequencing (Emanuel and Saitta, 2007). For
smaller variations, a combination of QTL identiﬁcation
followed by resequencing of individuals with well deﬁned
phenotypes is a powerful way to accurately identify the
actual structural variation that inﬂuences the trait of
interest (Soria et al., 2005; Kunieda et al., 2005). The
feasibility of this approach has increased dramatically with
the advent of new, rapid and less costly means of
sequencing. Modern short read sequencing technologies
can provide several gigabases of data in less than 48 h at a
fraction of the cost of the older platforms. As the speed and
cost continue to decrease, the feasibility of this approach
becomes limited only by our ability to deal with the
enormous amounts of data.
5.2.3. Identiﬁcation of metabolic and immunologic pathways
that inﬂuence resistance and/or pathology
The ﬁnal area where a ‘‘Genomic Toolbox’’ can be of
great value is in the identiﬁcation of host metabolic and

immunologic pathways induced during and after parasitic
infections. Prior to genomics research, the discovery of
important metabolic or immunologic pathways was similar
to that used to identify structural variations, i.e. a targeted,
candidate gene approach. In most cases this involved the
development of gene-speciﬁc primer sets followed by
differential RT-PCR of RNA samples from infected and
non-infected hosts. While these procedures told us much
about changes in expression proﬁles of a small number of
targeted genes (Canals et al., 1997, 1998; Almeria et al.,
2003), they were nonetheless limited in scope to only those
genes or pathways deemed ‘‘important’’. The advent of
holistic methods to interrogate the entire transcriptome
have allowed for experimental designs unencumbered by
predetermined criteria and are meant to discover new or
unique aspects of the parasite–host interaction. The most
commonly used methodology today is the microarray.
Microarray technology has been successful in the discovery
of a number of interactions not previously explored. A recent
report investigating the relationship between Cooperia
oncophora and its bovine host shows the complexity and
breadth of this interaction, and the need to look at pathways
not previously explored (Li and Gasbarre, 2009). Mackinnon
et al. (2009) recently used microarrays to evaluate gene
expression patterns among parasite-resistant and susceptible sheep species infected with H. contortus and proposed
that increased parasite resistance is associated with
stronger inﬂammatory responses in animals infected with
the parasite.
Although microarray technologies have the advantage
of simultaneously evaluating changes in whole transcriptomes, it nonetheless has severe limitations including high
rates of false positives and difﬁculties in accurate
quantiﬁcation (Cookson et al., 2009). The most promising
approach to addressing these shortcomings is nextgeneration sequencing platforms that permit sequencing
whole transcriptomes and at great depths (Shendure,
2008); however, this is not without its own challenges. The
very power of this methodology is its own Achilles heel, i.e.
massive amount of data. A single run on current
sequencers generates 4–5 terabytes of data, and in the
near future this ﬁgure will double. Thus, signiﬁcant
computer hardware and sophisticated bioinformatics
support is required. As these problems are addressed,
the technology will offer for the ﬁrst time, an opportunity
to accurately quantify all transcripts generated at speciﬁc
points during the host–parasite interaction. As such we are
entering an age where we can begin to clarify and
understand the total complexity of the interactome.
5.3. Methods by which host genetics could be used to control
parasitic infections
As an example of how the information derived from the
use of a ‘‘Genomic Toolbox’’ could be used to control
parasitic infections we can once again look at the heavily
studied relationship between gastrointestinal nematodes
and their ruminant hosts.
Among cattle breeds, adequate genetic variation is
coincident with resistance to nematode infection, and the
heritability of this trait is high enough that signiﬁcant
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genetic progress can be made by classic selection
programs. The question is: ‘‘Do parasites exert enough
economic pressure to warrant a selection program for this
trait?’’ The answer is less clear and regionally dependent.
For US producers in the Southeast, Northeast, and Northwest where stocking rates and parasite infections are
sufﬁciently high, genetic improvement could have a
profound affect on production efﬁciencies. In contrast,
stockmen in areas of low grazing density may not see
demonstrable improvement; however, they might still ﬁnd
an advantage to reducing parasites in animals based on
marginal nutritional planes. In addition, as questions on
land use and pesticide application become more important
to consumers, any program that reduces dependence on
anthelmintics will likely become more readily adopted by
producers.
A more important issue relates to the ramiﬁcations of
implementing breeding programs based on resistance to a
single disease entity. Resistance to GI nematodes is a
complex mixture of many types of immune responses and
host protection against dissimilar parasites is unlikely to
be congruent (Canals et al., 1997; Almeria et al., 1998;
Stear et al., 2007). It is also becoming evident that distinct
classes of immune responses, i.e. the so called Th1/Th2
paradigm, are counter-regulatory. Thus, animals that are
superior in some responses maybe inferior in others. This
issue coupled with the potential loss of diversity in
agricultural species makes it unlikely that major programs
will be implemented to breed for helminth resistance
except in areas exhibiting extremely high parasite
pressure.
Amidst the controversy in breeding for helminth
resistance in cattle, there are other ways that host genetics
could be used to increase the efﬁciency of cattle and dairy
production. One example is in dealing with nematodiasis
which is a ‘‘quantitative’’ disease; namely, as parasite
burdens increase so does loss. As such, very low
parasitemias are likely to induce little or no economic
effect in otherwise well-managed animals. With this in
mind, the goal of modern parasite control programs should
be to keep transmission rates low, and not eradicate the
parasites, albeit unrealistic. In conjunction with the
quantitative nature of the disease, the ‘‘overdispersed’’
character of nematode distributions must also be considered. This pattern implies that a few members of a herd
are responsible for most of the parasite transmission. In an
elegant analysis, Anderson and May (1985) calculated that
controlling disease by treating/removing/vaccinating susceptible animals would be nearly as effective as treating
the entire population. From an economic standpoint, rapid
and inexpensive genetic identiﬁcation of these ‘‘susceptible/non-responders’’ could reduce treatment costs substantially. Such an approach would lessen the selective
pressures placed on parasite populations, and should slow
the development of drug resistance. The key is in the
development of reliable markers for susceptibility/resistance.
In a similar manner, identiﬁcation of the genes involved
in protection should provide producers with the information to make educated breeding decisions. The past few
years have seen cattle producers move away from selecting
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for single traits and become more aware of the beneﬁts of
selecting for a variety of production traits. The use of
‘‘breeding values’’ is a common subject among cattle
producers. Providing producers with reliable genetic
information on the performance of their cattle under
parasite pressure will allow them to make informed
breeding decisions based upon this trait. Producers in areas
of high parasite pressure might choose not to use
‘‘susceptible’’ bulls, while those in areas with less parasite
transmission could use these bulls if they provided other
traits more important to their overall breeding programs.
Finally, as our ability to manipulate genomes becomes
more reﬁned, it will one day be possible to genetically
engineer food producing animals to meet the speciﬁc
needs of a given producer. The ability to do this with
parasite resistance will ﬁrst depend upon developing the
means to rapidly and reliably identify the resistance
phenotype of an individual animal. This will be followed by
deciphering the genes, the mechanisms, and the precise
regulatory processes involved.
6. The beginnings
Sequencing whole genomes and transcriptomes have
positioned parasitology at the very foundation of a new era
of investigative research. Next-generation advancements
in sequencing technologies now permit us to evaluate the
entire transcriptome of a 100 Mb organism to a depth of
100 coverage within a single set of experiments and in a
period of days rather than months or years. Data are being
generated at such alarming rates that the predictive value
of sequence analysis programs are unable to keep up with
the ﬂurry of new information (Lu et al., 2007). As this
industry moves forward, we hope one day to relate DNA
sequence to structure and eventually to function, and use
systems biology to gain holistic views of how the pieces
work together at the cellular, organism and environmental
levels. These are the goals of the 21st century parasitologist. But as we advance our understanding of genomes
and transcriptomes, and as databases continue to balloon
with information, we must not lose sight of factors other
than sequence order that can and do affect disease
outcomes.
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